DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mxwfmz/bladder_cancer) has announced the addition of the "Bladder Cancer Treatment Drugs Markets in China" report to their offering.
China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high-speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented.
Major producers in China are profiled.
Key Topics Covered:
II. BUSINESS ENVIRONMENT
III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK
VI. MARKETING STRATEGIES
VII. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY
- Schering-Plough China Inc.
- Bristol-Myers Squibb China Inc
For more information visit http://www.researchandmarkets.com/research/mxwfmz/bladder_cancer.